Featured Research

from universities, journals, and other organizations

Protein Stops Blood-Vessel Growth, Holds Promise

Date:
June 18, 2004
Source:
Jewish Medical And Research Center
Summary:
Researchers at National Jewish Medical and Research Center have identified a protein that inhibits the formation of new blood vessels.

Researchers at National Jewish Medical and Research Center have identified a protein that inhibits the formation of new blood vessels. Combined with previous findings that the protein is depleted or missing in a majority of metastatic human cancers, the findings suggest that fibulin-5 may one day be an effective cancer therapy. William Schiemann, Ph.D., Assistant Professor in the Program in Cell Biology at National Jewish, and postdoctoral fellow Allan R. Albig reported their findings in the June issue of DNA and Cell Biology.

"We believe fibulin-5 shows real promise as a cancer therapy," said Schiemann. "When we slightly altered the naturally occurring protein it was even more effective at inhibiting the sprouting of new blood vessels."

Cancer tumors need nutrients and oxygen supplied by blood vessels in order to grow. They also use blood vessels to spread to other parts of the body. This process, known as metastasis, is the most lethal characteristic of cancer and the leading cause of cancer-related death. The strategy of fighting cancer by preventing the growth of new blood vessels has generated great interest in recent years, with the first antiangiogenic drug being approved earlier this year.

Endothelial cells have been the target of most antiangiogenic strategies. Endothelial cells are specialized cells that develop into blood vessels. Fibulin-5, a member of a family of extracellular matrix proteins that regulate tissue development, remodeling and repair, interacts with endothelial cells.

In cell culture studies, Schiemann and Albig showed fibulin-5 levels drop significantly when endothelial cells begin to form blood vessels, a process known as tubulation. They also show that high levels of fibulin-5 could prevent the sprouting of new blood vessels by inhibiting the proliferation and movement of endothelial cells.

Fibulin-5 interfered with signaling by the proangiogenic factor VEGF, and increased levels of the antiangiogenic factor thrombospondin-1. The researchers believe that fibulin-5 may work by controlling the relative levels of VEGF and thrombospondin-1.

In a previous paper, published in 2002, Schiemann and his colleagues showed the fibulin-5 expression is reduced or lost in a majority of metastatic human malignancies. Schiemann believes that future research on fibulin-5 should focus on patients in whom tumors have not already metastasized. His group is continuing to examine fibulin-5 functions at the molecular level and will soon evaluate its effects in mice.

The protein may also serve as a diagnostic tool, a marker of cancer status. Rapidly dropping levels of fibulin-5 might signal a tumor preparing to grow and/or spread.

"The good thing about this protein is it's extra-cellular, especially as a diagnostic marker," said Emmanuel Hilaire, a technology transfer specialist at National Jewish. "It's very important because it's detectable in serum and urine."

A provisional patent citing the diagnostic merits of fibulin-5 has been filed with additional claims filed after researchers made their most recent observations.


Story Source:

The above story is based on materials provided by Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

Jewish Medical And Research Center. "Protein Stops Blood-Vessel Growth, Holds Promise." ScienceDaily. ScienceDaily, 18 June 2004. <www.sciencedaily.com/releases/2004/06/040618063413.htm>.
Jewish Medical And Research Center. (2004, June 18). Protein Stops Blood-Vessel Growth, Holds Promise. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2004/06/040618063413.htm
Jewish Medical And Research Center. "Protein Stops Blood-Vessel Growth, Holds Promise." ScienceDaily. www.sciencedaily.com/releases/2004/06/040618063413.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins